PATENT CLAIM ANALYSIS

Application Number: 15765082
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "649000"]

Abstract:
Methods of treating cancer include administering a therapeutically effective amount of a pharmaceutical composition containing a pharmaceutically acceptable carrier and a compound that is a GPR55 antagonist to a subject having a tumor including cancer cells that have developed a resistance to one or more chemotherapeutic agents. In embodiments, the compound is a fenoterol analogue, such as for example, MNF.

Claim (Index 6):
The method of  claim 1  wherein the pharmaceutical composition administered contains one or more compounds selected from the group consisting of (R,R\u2032)-4\u2032-methoxy-1-naphthylfenoterol (\u201cMNF\u201d), (R,S\u2032)-4\u2032-methoxy-1-naphthylfenoterol, (R,R\u2032)-ethylMNF, (R,R\u2032)-napthylfenoterol, (R,S\u2032)-napthylfenoterol, (R,R\u2032)-ethyl-naphthylfenoterol, (R,R\u2032)-4\u2032-amino-1-naphthylfenoterol, (R,R\u2032)-4\u2032-hydroxy-1-naphthylfenoterol, (R,R\u2032)-4\u2032-methoxy-ethylfenoterol, (R,R\u2032)-4\u2032-methoxyfenoterol, (R,R\u2032)-ethylfenoterol, (R,R\u2032)-fenoterol and their respective stereoisomers.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.35417
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15225643', '15273147', '12810457', '15126777', '15430123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8016235380977141
- 35 USC 102 Novelty (BERT): 0.5572149664772367
- Combined Prediction Score: 0.7771826809356663
- Mean Citation Score: 286.826548
- Max Citation Score: 427.44946
- Similarity Product: 378.7080589870548

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test